HLB-Pharma Laboratory: Nine Preventable Deaths

On Tuesday, May 13, provision No. 3158/25 of ANMAT was published in the Official Gazette, inhibiting the productive activities of the pharmaceutical companies HLB Pharma Group S.A. and Laboratorios Ramallo S.A. In turn, the provision also prohibits the use, distribution and marketing throughout the Argentine territory of all the products of those firms, until the appropriate technical and sanitary conditions for lifting the measure are met. The …